The appellant, C.B., appealed two decisions of the Consent and Capacity Board: one confirming a Community Treatment Order (CTO) and its Community Treatment Plan (CTP), and another confirming his incapacity regarding treatment with antipsychotic medications.
The court upheld the Board's finding of incapacity for antipsychotic medication, applying the correct legal test and finding no palpable and overriding error.
The appeal regarding the CTO and CTP was dismissed as moot because the May 2021 CTO had expired, a new CTO was issued based on a fresh capacity assessment, and this new CTO was subsequently confirmed by the Board.
The court declined to exercise its discretion to hear the moot issues, citing a change in the evidentiary basis of the dispute and judicial economy.